Commercial Credit Report for Insulet Corp

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Insulet Corp is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Insulet Corp
100 Nagog Park
Phone: (978) 600-7000p:978 600-7000	ACTON, MA 01720-3440 United States	Ticker: PODDPODD

Business Summary

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	Yes	Yes	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	Yes	-	Yes	Yes

Industries

SIC Code	Description
3841	Surgical and medical instruments and apparatus

Officers and Directors

Title	Name	Age	Title Date	Start Date
Independent Chairman of the Board	Timothy J.Scannell	59	1/1/2019	8/12/2014
President, Chief Executive Officer, Director	James R.Hollingshead	60	6/1/2022	7/31/2019
Chief Accounting Officer, Group Vice President, Controller	LaurenBudden	48	4/22/2024	10/20/2023
11 additional Officers and Directors records available in full report.

Business Names

Business Name
Insulet Asia (Singapore) Pte. Ltd.
Insulet Australia Pty Ltd
Insulet Austria GmbH
19 additional Business Names available in full report.

General Information

Number of Employees:	3,000	(As of 12/31/2023)
Outstanding Shares:	70,022,493	(As of 3/26/2024)
Shareholders:	6
Stock Exchange:	NASD
Federal Tax Id:	043523891
Fax Number:	(978) 600-0120

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN